Bank of New York Mellon’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-38,065
| Closed | -$1.06M | – | 4285 |
|
|
2019
Q3 | $1.06M | Sell |
38,065
-1,693
| -4% | -$47.3K | ﹤0.01% | 3142 |
|
|
2019
Q2 | $560K | Sell |
39,758
-6,680
| -14% | -$94.1K | ﹤0.01% | 3542 |
|
|
2019
Q1 | $413K | Sell |
46,438
-3,469
| -7% | -$30.9K | ﹤0.01% | 3626 |
|
|
2018
Q4 | $378K | Buy |
49,907
+2,313
| +5% | +$17.5K | ﹤0.01% | 3615 |
|
|
2018
Q3 | $998K | Buy |
47,594
+1,220
| +3% | +$25.6K | ﹤0.01% | 3252 |
|
|
2018
Q2 | $1.39M | Buy |
46,374
+30,750
| +197% | +$920K | ﹤0.01% | 3058 |
|
|
2018
Q1 | $423K | Buy |
15,624
+383
| +3% | +$10.4K | ﹤0.01% | 3646 |
|
|
2017
Q4 | $439K | Buy |
15,241
+1,243
| +9% | +$35.8K | ﹤0.01% | 3656 |
|
|
2017
Q3 | $340K | Buy |
+13,998
| New | +$340K | ﹤0.01% | 3717 |
|